A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB

被引：0
|
作者：
Ke, X.
Kavati, A.
Wertz, D.
Huang, Q.
Wang, L.
Willey, V.
Stephenson, J.
Ortiz, B.
Panettieri, R., Jr.
Corren, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P211
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [1] A REAL-WORLD ASSESSMENT OF OMALIZUMAB TREATMENT PATTERNS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
  • [2] Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Wang, Liya
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Panettieri, Reynold A., Jr.
    Corren, Jonathan
    [J]. CLINICAL THERAPEUTICS, 2018, 40 (07) : 1140 - 1158
  • [3] Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
    Szabo, Melinda
    Chlumsky, Jan
    Maykut, Robert
    Georgiou, Panayiotis
    Chen, Chien-Wei
    Peachey, Guy
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [4] Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal
    Sousa, A. S.
    Pereira, A. M.
    Fonseca, J. A.
    Azevedo, L. F.
    Abreu, C.
    Arrobas, A.
    Calvo, T.
    Silvestre, M. J.
    Cunha, L.
    Falcao, H.
    Drummond, M.
    Geraldes, L.
    Loureiro, C.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (06) : 327 - 333
  • [5] REDUCTIONS IN EXACERBATIONS IN PATIENTS WITH ALLERGIC (IGE-MEDIATED) ASTHMA RECEIVING OMALIZUMAB IN A REAL-WORLD SETTING
    Kuo, H. P.
    Canvin, J.
    Maykut, R.
    Bruce, J.
    Chen, C. W.
    Braunstahl, G. J.
    [J]. RESPIROLOGY, 2012, 17 : 11 - 11
  • [6] A REAL WORLD PROFILE OF THE BASELINE CHARACTERISTICS OF ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB IN THE UNITED STATES
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V. J.
    Stephenson, J. J.
    Ortiz, B.
    Panettieri, Jr R. A.
    Corren, J.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A207 - A207
  • [7] Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use with Omalizumab from the Real-World PROSPERO Study
    Casale, Thomas B.
    Iqbal, Ahmar
    Dang, Joseph
    Yang, Ming
    Rajput, Yamina
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB99 - AB99
  • [8] Real-world Omalizumab and Mepolizumab Treated Difficult Asthma Phenotypes and Their Clinical Outcomes
    Fong, W. C. G.
    Azim, A.
    Knight, D.
    [J]. PEDIATRICS, 2021, 148 : S64 - S65
  • [9] Real-world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes
    Fong, Wei Chern Gavin
    Azim, Adnan
    Knight, Deborah
    Mistry, Heena
    Freeman, Anna
    Felongco, Mae
    Kyyaly, Aref
    Harvey, Matthew
    Dennison, Patrick
    Zhang, Hongmei
    Howarth, Peter
    Arshad, Syed Hasan
    Kurukulaaratchy, Ramesh J.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (08): : 1019 - 1032
  • [10] Assessment of asthma exacerbations in a real-world setting over 4 years
    O'Connor, R
    Tashkin, D
    Peters, S
    Long, A
    Bleecker, E
    Parasuraman, B
    Boggs, R
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S275 - S275
12345